Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The study drug, Aprepitant, is currently used to control chemotherapy induced nausea and
vomiting and is also approved for post-operative nausea and vomiting. The investigators'
evaluation of it in morbidly obese patients will demonstrate its ability to control nausea
and vomiting post-operatively in this subset of patients.